By comparing the expression of PCYT1B in human hepatocellular carcinoma (HCC) of different grades and in normal tissues, we found that expression of this enzyme was significantly high in normal tissues but strongly declined in high-grade tumors, negatively correlating with tumor progression (Figure 5A). Here, PCYT1B is linked to neoplasm.